Oncologic and functional outcomes of open surgery in early supraglottic tumors: is it still a valid technique?
OBJECTIVE
In this study, we aimed to analyze the oncologic and functional outcomes of supraglottic laryngectomy.


METHODS
Medical records of 91 cases (85 males, 6 females; mean age 55.4 years; range 30 to 75 years) who underwent surgery due to early supraglottic laryngeal cancer in our clinic were retrospectively analyzed. Statistical analysis was performed using chi-square test and Fisher's exact test. Mean values were estimated by means of t-test, while survival curves were drawn using Kaplan-Meier method.


RESULTS
With respect to oncologic assessment, disease-free survival rate was 81%, the rate of regional recurrence was 6%, the rate of local recurrence was 8%, the rate of distant metastasis was 7% and the rate of occult neck metastasis was 25%. Metastatic neck disease and extracapsular invasion in the lymphatic ganglia were found to be the most critical parameters in terms of survival. With respect to functional assessment, the mean time of decannulation was 41 days, while the mean time of nasogastric tube removal was 19 days. It was observed that cases with a Forced Expiratory Volume in 1 second (FEV-1) of <75% experienced more aspiration-related problems. The functional outcomes were worse in the cases who underwent bilateral neck dissection and postoperative radiotherapy.


CONCLUSIONS
Open surgery is a more effective treatment modality in the early supraglottic tumors in terms of oncologic and functional outcomes. It should be continued to be use as an alternative method to the novel and expensive technologies including transoral robotic surgery or transoral laser surgery.
Department of Otolaryngology, Medicine Faculty of İstanbul University, Fatih, İstanbul, Turkey.
Murat
M
Ulusan
Bora
B
Başaran
Kadir Serkan
KS
Orhan
Senol
S
Comoğlu
Karolin
K
Yıldırmaz
Okkeş Erkan
OE
Kıyak
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000473:pathology / Q000601:surgery*; D018572:Disease-Free Survival; D004825:Epiglottis / Q000473:pathology; D005260:Female; D006258:Head and Neck Neoplasms / Q000556:secondary / Q000601:surgery; D006801:Humans; D007822:Laryngeal Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000601:surgery*; D007825:Laryngectomy / Q000379:methods*; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D037981:Neck Dissection / Q000706:statistics & numerical data; D060787:Neoplasm Grading; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology* / Q000473:pathology / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D053120:Respiratory Aspiration / Q000453:epidemiology / Q000209:etiology; D012189:Retrospective Studies